Martin Cannon is the founder of New Health Sciences. New Health Sciences has raised $100M in total funding. Latest round: Series B. Backed by NIH.
Martin Cannon founded Hemanext in 2008, supported by a National Institutes of Health (NIH) grant. He retired from Hemanext in September 2023. Cannon is recognized for his foresight in enhancing red blood cell quality, leading to a commercially viable medical device for hypoxic storage of RBCs.
Full founder directory · Investor directory · Company funding database · Fundraising library